ACE and nephrosclerosis: Studies in an animal model suggested that SLV306 had a similar efficacy to the angiotensin converting enzyme (ACE) inhibitor captopril in reducing proteinuria and preventing nephrosclerosis (Thone-Reinke et al., 2004).